Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design

Vaccine

Volumn 34, Issue 4, 2016, Pages 479-485

  Ali, Mohammad ^a,b   You, Young Ae ^a   Sur, Dipika ^c   Kanungo, Suman ^c   Kim, Deok Ryun ^a   Deen, Jacqueline ^b   Lopez, Anna Lena ^d   Wierzba, Thomas F ^a   Bhattacharya, Sujit K ^c   Clemens, John D ^e,f  

^a International Vaccine Institute   (South Korea)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^d UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^e INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Case control; Cholera; Test negative design; Vaccine efficacy; Vaccine trial

Indexed keywords

CHOLERA VACCINE; PLACEBO;

ADOLESCENT; ARTICLE; BANGLADESH; CHILD; CHOLERA; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; HUMAN; INDIA; MAJOR CLINICAL STUDY; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TANZANIA; TEST NEGATIVE DESIGN; VACCINATION; VALIDITY; VIBRIO CHOLERAE O1; IMMUNOLOGY; MICROBIOLOGY; PROPORTIONAL HAZARDS MODEL; STANDARDS; VALIDATION STUDY;

BANGLADESH; CHOLERA; CHOLERA VACCINES; COHORT STUDIES; DIARRHEA; HUMANS; INDIA; PROPORTIONAL HAZARDS MODELS; RESEARCH DESIGN; TANZANIA; VIBRIO CHOLERAE O1;

EID: 84952915004     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.12.004     Document Type: Article

References (29)

1. Begg N., Miller E. Role of epidemiology in vaccine policy. Vaccine 1990, 8:180-189.
2. Orenstein W.A., Bernier R.H., Hinman A.R. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988, 10:212-241.
3. Clarkson J.A., Fine P.E.M. An assessment of methods for routine local monitoring of vaccine efficacy, with particular reference to measles and pertussis. Epidemiol Infect 1987, 99:485-499.
4. Hatton P. The use of the screening technique as a method of rapidly estimating vaccine efficacy. Public Health 1990, 104:21-25.
5. Palmer S.R. Vaccine efficacy and control measures in pertussis. Arch Dis Child 1991, 66:854-857.
6. Ramsay M.E., Farrington C.P., Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect 1993, 111(1):41-48.
7. Jacksona M.L., Nelsona J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
8. De Serres G., Skowronski D.M., Wu X.W., Ambrose C.S. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Eurosurveillance 2013, 18(37). 20585.
9. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30):3104-3109.
10. Wierzba T.W., Kar S.K., Mogasale V.V., Kerketta A.S., You Y.A., Baral P., et al. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha state, India. Vaccine 2015, 33(21):2463-2469.
11. Broome C.V., Facklam R.R., Fraser D.W. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 1980, 303(10):549-552.
12. Patel M.M., Patzi M., Pastor D., Nina A., Roca Y., Alvarez L., et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. Br Med J 2013, 346:f3726.
13. Patel M., Pedreira C., de Oliveira L.H., Umaña J., Tate J., Lopman B., et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012, 130(2):e365-e372.
14. Castilla J., Beristain X., Martínez-Artola V., Navascués A., García Cenoz M., Alvarez N., et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 2012, 30(3):539-543.
15. Yen C. The development of global vaccine stockpiles. Lancet Infect Dis 2015, 15:340-347.
16. Clemens J.D., Sack D.A., Harris J.R., Van Loon F., Chakraborty J., Ahmed F., et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 1990, 335(8684):270-273.
17. Bhattacharya S.K., Sur D., Ali M., Kanungo S., You Y.A., Manna B., et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2013, 13:1050-1056.
18. Khatib A.M., Ali M., von Seidlein L., Kim D.R., Hashim R., Reyburn R., et al. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis 2012, 12(11):837-844.
19. Bopp C., Ries A., Wells J. Laboratory methods for the diagnosis of epidemic dysentery and cholera 1999, Centers for Disease Control and Prevention, Atlanta.
20. The treatment of diarrhea: a manual for physicians and other senior health workers 2005, WHO, World Health Organization, Geneva, (4th revision).
21. Clemens J.D., Sack D.A., Harris J.R., Chakraborty J., Neogy P.K., Stanton B., et al. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 1988, 158(2):372-377.
22. Peduzzi P., Concato J., Kemper E., Holford T.R., Feinstein A.R. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49(12):1373-1379.
23. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009, 199:159-167.
24. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M., Shone L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008, 122:911-919.
25. Belongia E.A., Kieke B.A., Donahue J.G., Coleman L.A., Irving S.A., Meece J.K., et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011, 29(38):6558-6563.
26. Benowitz I., Esposito D.B., Gracey K.D., Shapiro E.D., Vazquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010, 51(12):1355-1361.
27. Kelly H., Jacoby P., Dixon G.A., Carcione D., Williams S., Moore H.C., et al. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J 2011, 30(2):107-111.
28. Ferdinands J.M., Shay D.K. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. Clin Infect Dis 2012, 54(1):25-32.
29. Kopec J.A., Esdaile J.M. Bias in case-control studies. A review. J Epidemiol Community Health 1990, 44(3):179-186.